XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative effect, period of adoption, adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative effect, period of adoption, adjustment
 Retained Earnings
 Retained Earnings
Cumulative effect, period of adoption, adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative effect, period of adoption, adjustment
Beginning balance (in shares) at Dec. 31, 2017     6,872,000            
Beginning balance, value at Dec. 31, 2017 $ 192,802   $ 6,872 $ 61,793   $ 124,407   $ (270) $ (191)
Beginning balance, value (Accounting Standards Update 2017-08) at Dec. 31, 2017   $ (62)         $ (62)   0
Beginning balance, value (Accounting Standards Update 2016-01) at Dec. 31, 2017   0         191   $ (191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cash dividend declared (7,088)         (7,088)      
Stock-based compensation expense 816     816          
Exercise of stock options and vesting of restricted stock units, net (in shares)     27,000            
Exercise of stock options and vesting of restricted stock units, net $ 28   $ 27 1          
Repurchase of common stock (in shares) (15,468)   (16,000)            
Repurchase of common stock $ (494)   $ (16) (478)          
Other comprehensive income (loss), net of tax (59)             (59)  
Net income 20,004         20,004      
Ending balance (in shares) at Dec. 31, 2018     6,883,000            
Ending balance, value at Dec. 31, 2018 205,947   $ 6,883 62,132   137,452   (520)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cash dividend declared (8,528)         (8,528)      
Stock-based compensation expense 832     832          
Exercise of stock options and vesting of restricted stock units, net (in shares)     24,000            
Exercise of stock options and vesting of restricted stock units, net $ (207)   $ 24 (231)          
Repurchase of common stock (in shares) (347,676)   (348,000)            
Repurchase of common stock $ (12,569)   $ (348) (12,221)          
Other comprehensive income (loss), net of tax $ 951             951  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201609Member                
Net income $ 20,691         20,691      
Ending balance (in shares) at Dec. 31, 2019 6,558,809   6,559,000            
Ending balance, value at Dec. 31, 2019 $ 207,117 $ 0 $ 6,559 50,512 $ 139 149,615 $ (139) 431  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cash dividend declared (8,866)         (8,866)      
Stock-based compensation expense 943     943          
Exercise of stock options and vesting of restricted stock units, net (in shares)     19,000            
Exercise of stock options and vesting of restricted stock units, net $ (118)   $ 19 (137)          
Repurchase of common stock (in shares) (327,000)   (327,000)            
Repurchase of common stock $ (9,976)   $ (327) (9,649)          
Other comprehensive income (loss), net of tax (413)             (413)  
Net income $ 32,888         32,888      
Ending balance (in shares) at Dec. 31, 2020 6,251,004   6,251,000            
Ending balance, value at Dec. 31, 2020 $ 221,575   $ 6,251 $ 41,808   $ 173,498   $ 18